MedPath

TADAM, a Belgian project of Heroin-Assisted Treatment - TADAM

Phase 1
Conditions
treatment resistant heroin addiction
Registration Number
EUCTR2010-019026-13-BE
Lead Sponsor
niversity of Liège
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Treatment-resistant heroin dependency, as indicated by:
- heroin dependency for at least 5 years,
- heroin addiction is the main dependency,
- daily or almost daily use of illicit heroin,
- previous experience of methadone treatment,
Legal resident in the judicial district of Liège for at least 12 months,
A minimum age of 20 years,
Willing to attend the treatment site at least twice a day,
Willing to attend a psychosocial follow-up
Written consent

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Persons who had voluntary phase of abstinence of at least 2 months during the last 12 months
Pregnancy
Diagnosis of severe medical or psychiatric conditions that are contra-indicated for the study conditions

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath